Terms: = Head and neck cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Prognosis
17 results:
1. miR-551b is Associated with the Poor prognosis and Malignant Development of Papillary Thyroid cancer Through Regulating erbb4.
Wang J; Liu H
Horm Metab Res; 2022 Feb; 54(2):113-118. PubMed ID: 35130572
[TBL] [Abstract] [Full Text] [Related]
2. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
3. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma.
Huang CL; Chen Y; Guo R; Mao YP; Xu C; Tian L; Liu LZ; Lin AH; Sun Y; Ma J; Tang LL
Cancer Med; 2020 Oct; 9(19):7100-7106. PubMed ID: 32794334
[TBL] [Abstract] [Full Text] [Related]
5. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract] [Full Text] [Related]
7. Expressions and clinical significance of her4 and CD44 in sinonasal mucosal malignant melanoma.
Zhu W; Li S; Zou B; Liu H; Wang S
Melanoma Res; 2018 Apr; 28(2):105-110. PubMed ID: 29309357
[TBL] [Abstract] [Full Text] [Related]
8. Afatinib against Esophageal or head-and-neck Squamous Cell Carcinoma: Significance of Activating Oncogenic her4 Mutations in HNSCC.
Nakamura Y; Togashi Y; Nakahara H; Tomida S; Banno E; Terashima M; Hayashi H; de Velasco MA; Sakai K; Fujita Y; Okegawa T; Nutahara K; Hamada S; Nishio K
Mol Cancer Ther; 2016 Aug; 15(8):1988-97. PubMed ID: 27207775
[TBL] [Abstract] [Full Text] [Related]
9. The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas.
Martinez-Useros J; Garcia-Foncillas J
Oral Oncol; 2015 May; 51(5):423-30. PubMed ID: 25753560
[TBL] [Abstract] [Full Text] [Related]
10. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.
Ribeiro FA; Noguti J; Oshima CT; Ribeiro DA
Anticancer Res; 2014 Apr; 34(4):1547-52. PubMed ID: 24692681
[TBL] [Abstract] [Full Text] [Related]
11. Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.
Ribeiro IP; Marques F; Caramelo F; Pereira J; Patrício M; Prazeres H; Ferrão J; Julião MJ; Castelo-Branco M; de Melo JB; Baptista IP; Carreira IM
Cell Oncol (Dordr); 2014 Feb; 37(1):29-39. PubMed ID: 24353162
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical expression patterns of the her4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the her4 protein in laryngeal squamous cell carcinoma.
Bussu F; Ranelletti FO; Gessi M; Graziani C; Lanza P; Lauriola L; Paludetti G; Almadori G
Laryngoscope; 2012 Aug; 122(8):1724-33. PubMed ID: 22549618
[TBL] [Abstract] [Full Text] [Related]
13. Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors.
Cruz-López O; Conejo-García A; Núñez MC; Kimatrai M; García-Rubiño ME; Morales F; Gómez-Pérez V; Campos JM
Curr Med Chem; 2011; 18(7):943-63. PubMed ID: 21254978
[TBL] [Abstract] [Full Text] [Related]
14. EGFR (HER) family protein expression and cytogenetics in 219 squamous cell carcinomas of the upper respiratory tract: ERBB2 overexpression independent prediction of poor prognosis.
Brunner K; Fischer CA; Driemel O; Hartmann A; Brockhoff G; Schwarz S
Anal Quant Cytol Histol; 2010 Apr; 32(2):78-89. PubMed ID: 20701076
[TBL] [Abstract] [Full Text] [Related]
15. HER family receptors expression in squamous cell carcinoma of the tongue: study of the possible prognostic and biological significance.
Del Sordo R; Angiero F; Bellezza G; Cavaliere A; Mameli MG; Stefani M; Dessy E; Sidoni A
J Oral Pathol Med; 2010 Jan; 39(1):79-86. PubMed ID: 19691460
[TBL] [Abstract] [Full Text] [Related]
16. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract] [Full Text] [Related]
17. Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma.
Xu S; Kitayama J; Yamashita H; Souma D; Nagawa H
J Surg Oncol; 2008 Jan; 97(1):44-50. PubMed ID: 18000820
[TBL] [Abstract] [Full Text] [Related]
